Impact of Paresthesia on Postoperative Neurological Symptoms
NCT ID: NCT06906458
Last Updated: 2025-11-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2025-04-11
2025-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pericapsular Nerve Group Block in Shoulder Surgery
NCT05940454
Effect of Pericapsular Nerve Block on the Quality of Recovery After Shoulder Arthroscopy
NCT06225089
Interscalene Versus Costoclavicular Blocks for Shoulder Surgery
NCT06953947
Effect of Pericapsular Nerve Group Block on Postoperative Cognitive Function
NCT06736405
Peroperative Effect of Regional Anesthesia in Hip Surgery
NCT05960253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the operating room, possible complications related to the block (paresthesia, Horner's syndrome, dyspnea, hoarseness) will be monitored in the preoperative area. During the intraoperative period, data such as pulse, blood pressure, infusion fluids, intraoperative remifentanil requirements, anesthesia duration, and surgical time will be recorded.
In the postoperative period, postoperative pain status, block duration, postoperative nausea and vomiting, need for rescue analgesics and antiemetics, and QoR-15 scores on the first day will be assessed in the recovery room and ward. Additionally, postoperative neurological symptoms and QoR-15 scores will be followed via telephone on the 3rd, 7th, 10th, and 30th days after discharge.
For patients developing postoperative pain, pain intensity will be evaluated using an 11-point numeric rating scale, where 0 indicates no symptoms and 10 represents maximum severity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Paresthesia
Patients experiencing paresthesia during the interscalene nerve block
Paresthesia
Patients experiencing paresthesia during the interscalene nerve block
No paresthesia
Patients not experiencing paresthesia during the interscalene nerve block
No paresthesia
Patients not experiencing paresthesia during the interscalene nerve block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Paresthesia
Patients experiencing paresthesia during the interscalene nerve block
No paresthesia
Patients not experiencing paresthesia during the interscalene nerve block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range of 18-65 years
* Patients planned for interscalene nerve block for analgesia prior to arthroscopic shoulder surgery in the beach chair position under general anesthesia
Exclusion Criteria
* history of drug use
* Patient's refusal to participate in the study
* Psychiatric disorders
* Central nervous system diseases
* Vestibular disorders
* Presence of diabetes, neuropathy, and paralysis
* Pregnancy
* Open shoulder surgery
* Allergy to local anesthetics
* Coagulopathy
* Severe thrombocytopenia
* Infection at the puncture site
* Pre-existing neuropathy in the limb to be operated on
* Use of opioid and antiemetic medications before surgery
* Use of dexamethasone
* Lung disease
* Low baseline oxygen saturation
* Patients who cannot cooperate in the postoperative period (e.g., mental retardation, delirium, language acquisition deficiency, etc.)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gökhan Erdem
Anesthesiology and Reanimation specialist doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Bilkent City Hospital
Ankara, Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Paresthesia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.